Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 574

1.

An unusual case of primary hepatic lymphoma with dramatic but unsustained response to bendamustine plus rituximab and literature review.

Liao SH, Chen YK, Yu SC, Wu MS, Wang HP, Tseng PH.

SAGE Open Med Case Rep. 2017 May 26;5:2050313X17709190. doi: 10.1177/2050313X17709190. eCollection 2017.

2.

A novel anti-CD22 scFv-apoptin fusion protein induces apoptosis in malignant B-cells.

Agha Amiri S, Shahhosseini S, Zarei N, Khorasanizadeh D, Aminollahi E, Rezaie F, Zargari M, Azizi M, Khalaj V.

AMB Express. 2017 Dec;7(1):112. doi: 10.1186/s13568-017-0410-5. Epub 2017 Jun 2.

3.

Unmet needs in the scientific approach to older patients with lymphoma.

Bron D, Aurer I, André MPE, Bonnet C, Caballero D, Falandry C, Kimby E, Soubeyran P, Zucca E, Bosly A, Coiffier B; European Lymphoma Institute (ELI) Group and the EHA SWG “Aging and Hematology”.

Haematologica. 2017 Jun;102(6):972-975. doi: 10.3324/haematol.2017.167619. No abstract available.

4.

Primary Orbital Follicular Lymphoma: A Case Report and Review.

Prasad GL, Hegde A, Menon G, Mathew M.

J Clin Diagn Res. 2017 Mar;11(3):XD01-XD03. doi: 10.7860/JCDR/2017/24674.9400. Epub 2017 Mar 1.

5.

Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: A case report.

Cubo AM, Soto ZM, Cruz MÁ, Doyague MJ, Sancho V, Fraino A, Blanco Ó, Puig N, Alcoceba M, González M, Sayagués JM.

Medicine (Baltimore). 2017 May;96(19):e6846. doi: 10.1097/MD.0000000000006846.

6.

Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?

Amin AD, Peters TL, Li L, Rajan SS, Choudhari R, Puvvada SD, Schatz JH.

Cold Spring Harb Mol Case Stud. 2017 May;3(3):a001719. doi: 10.1101/mcs.a001719. Review.

7.

Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy.

Cheungpasitporn W, Kopecky SL, Specks U, Bharucha K, Fervenza FC.

J Renal Inj Prev. 2016 Nov 2;6(1):18-25. doi: 10.15171/jrip.2017.04. eCollection 2017.

8.

Malignant lymphoma on parotid gland: a clinical case.

Lee HG, Lee JY, Song JM.

J Korean Assoc Oral Maxillofac Surg. 2017 Apr;43(2):138-143. doi: 10.5125/jkaoms.2017.43.2.138. Epub 2017 Apr 25.

9.

Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis.

Wang J, Zhou X, Liu Y, Li Z, Li X.

PLoS One. 2017 Apr 25;12(4):e0176008. doi: 10.1371/journal.pone.0176008. eCollection 2017.

10.

Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma.

Kusano Y, Yokoyama M, Terui Y, Nishimura N, Mishima Y, Ueda K, Tsuyama N, Hirofumi Y, Takahashi A, Inoue N, Takeuchi K, Hatake K.

Blood Cancer J. 2017 Apr 21;7(4):e558. doi: 10.1038/bcj.2017.37.

11.

Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithm.

Yoon N, Ahn S, Yong Yoo H, Jin Kim S, Seog Kim W, Hyeh Ko Y.

Oncotarget. 2017 Mar 28;8(13):22014-22022. doi: 10.18632/oncotarget.15782.

12.

The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients.

Broccoli A, Casadei B, Stefoni V, Pellegrini C, Quirini F, Tonialini L, Morigi A, Marangon M, Argnani L, Zinzani PL.

BMC Cancer. 2017 Apr 17;17(1):276. doi: 10.1186/s12885-017-3269-6.

13.

Primary Extranodal Diffuse Large B-Cell Lymphoma of the Prostate: A Case Report.

Ezekwudo DE, Ogunleye F, Gbadamosi B, Blankenship LM, Kinoyan M, Krauss D, Hollander M, Haberichter K, Jaiyesimi I.

Case Rep Oncol. 2017 Feb 15;10(1):199-204. doi: 10.1159/000457117. eCollection 2017 Jan-Apr.

14.

Comparison of Ifosfamide, Carboplatin and Etoposide versus Etoposide, Steroid, and Cytarabine Cisplatin as Salvage Chemotherapy in Patients with Refractory or Relapsed Hodgkin's lymphoma.

Mehrzad V, Ashrafi F, Farrashi AR, Pourmarjani R, Dehghani M, Shahsanaei A.

Adv Biomed Res. 2017 Mar 7;6:30. doi: 10.4103/2277-9175.201687. eCollection 2017.

15.

All That Wheezes Is Not Asthma: A Case of Diffuse Large B-Cell Lymphoma of the Larynx.

Rahman B, Bilal J, Sipra QU, Riaz IB.

Case Rep Oncol Med. 2017;2017:7072615. doi: 10.1155/2017/7072615. Epub 2017 Mar 15.

16.

Antibody-targeted paclitaxel loaded nanoparticles for the treatment of CD20+ B-cell lymphoma.

Nevala WK, Butterfield JT, Sutor SL, Knauer DJ, Markovic SN.

Sci Rep. 2017 Apr 5;7:45682. doi: 10.1038/srep45682.

17.

Role of MYC in B Cell Lymphomagenesis.

Korać P, Dotlić S, Matulić M, Zajc Petranović M, Dominis M.

Genes (Basel). 2017 Apr 4;8(4). pii: E115. doi: 10.3390/genes8040115. Review.

18.

Extranodal involvement in young patients with diffuse large B-cell lymphoma: distribution, prognostic value and treatment options.

Yao S, Li J, Yao Z, Xu Y, Chu J, Zhang J, Jin S, Huang Y, Zhang J, Ma J, Zhao Y, Yang S, Liu Y.

Chin J Cancer Res. 2017 Feb;29(1):57-65. doi: 10.21147/j.issn.1000-9604.2017.01.07.

19.

Spontaneous Remission of an Untreated, MYC and BCL2 Coexpressing, High-Grade B-Cell Lymphoma: A Case Report and Literature Review.

Potts DA, Fromm JR, Gopal AK, Cassaday RD.

Case Rep Hematol. 2017;2017:2676254. doi: 10.1155/2017/2676254. Epub 2017 Feb 21.

20.

Investigation on treatment strategy, prognostic factors, and risk factors for early death in elderly Taiwanese patients with diffuse large B-cell lymphoma.

Cho SF, Liu YC, Hsiao HH, Huang CT, Tsai YF, Wang HC, Lin SF, Liu TC.

Sci Rep. 2017 Mar 14;7:44282. doi: 10.1038/srep44282.

Supplemental Content

Support Center